Manufacturer¿s ref.No: (b)(4).No device was received for analysis at the time of submission of the initial 3500a.Since the product was not returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors could be made.Device history record (dhr) review cannot be conducted because the lot number was provided by the customer.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
|
This complaint is from a literature source.The following complications were reported in this publication: it was reported that 1 patient underwent coil embolization of an intracranial aneurysm and suffered a stroke at post op day 2 related to procedure.Patient treated with a combination of matrix and bpcs (which includes dsc).Intervention was not reported.There are 0 device malfunctions reported in this publication.Model and catalog number are not available, but the suspected device is: dcs.Other cnv devices that were also used in this study: prowler 14-microcatheter, agility 10, agility 14.Non-cnv devices that were also used in this study: artis, (siemens), synchro 10, synchro 14, matrix coils, guglielmi detachable coils.Title: polyglycolide/polylactide-coated platinum coils for patients with ruptured and unruptured cerebral aneurysms: a single-center experience.Objective: recanalization of cerebral aneurysm is a limitation of bare platinum coils (bpcs).In a swine aneurysm model, polyglycolide/polylactide (a polymer)-coated platinum coils (matrix) accelerated clot fibrosis and reduced recanalization rate and aneurysmal volume.We aimed to evaluate the safety of matrix coils in patients with intracranial aneurysm.Methods: this is a single-center, prospective study of patients with intracranial aneurysms treated with matrix alone or in combination with bpcs.Follow-up evaluation included a 1-month clinical evaluation and a 6- and 12-month clinical and angiographic examination.Primary adverse events included death, stroke, and permanent neurological deficits.
|